MedPath
NMPA Approval

Thymopentin for Injection

国药准字H20083746

February 8, 2023

Drug Information

注射用胸腺五肽

注射剂

1mg

化学药品

February 8, 2023

Company Information

Applicant Company

武汉经济技术开发区海特科技园

Manufacturing Company

湖北省武汉经济技术开发区海特科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用胸腺五肽 - NMPA 批准文号 | MedPath